Scholar Rock Holding is a biopharmaceutical company committed to discovering and developing innovative medicines that target the transforming growth factor beta (TGFβ) superfamily of proteins to treat serious diseases with high unmet medical need.

scholar-rock-holding

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div><span style="font-size: 11pt;">Reporting to the SVP, Finance, the Senior Accounting Manager will manage the monthly close process and help ensure closing timelines are maintained.&nbsp; The Senior Accounting Manager will serve as the primary coordinator for the Concur platform and the corporate credit card program, as well as oversee the Accounts Payable function.&nbsp; The Accounting Manager will incorporate/maintain processes to ensure compliance with SOX, as well as external reporting requirements. The ideal candidate for this position will excel in a rapidly evolving environment.&nbsp; The candidate should be able to analyze processes and propose and execute necessary process improvements. The candidate should be able to maintain a positive attitude while staying organized in a fast-paced, growth environment.&nbsp; This role will require strong organization, clear communication, attention to detail and a great sense of teamwork and will help to build a critical function at a growing and evolving, multi-product candidate biotechnology company.</span></div>

Senior Accounting Manager

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is transitioning from a clinical-stage organization to a commercial-stage biotech, and IT Service Delivery sits at the center of that transformation. We are looking for a dynamic, hands-on leader to stabilize and elevate our IT service desk while laying the foundation for a modern, scalable, and customer-centric service model. This role offers significant visibility, ownership, and influence. You will shape how IT is experienced across the company—supporting a diverse workforce of onsite, hybrid, and remote users—while partnering closely with internal teams and external managed service providers.</div><div><br></div><div>As Associate Director/ Director of IT Service Delivery, you will:</div><div> • Own the end-to-end employee IT support experience</div><div> • Lead internal support staff and manage external managed service providers</div><div> • Establish operational rigor, service reliability, and stakeholder trust</div><div> • Drive continuous improvement and long-term transformation of IT service delivery</div><div><br></div><div>You will stabilize what exists today, then evolve it into a best-in-class service organization aligned with a regulated, fast-growing biotech environment.</div><div><br></div>

Associate Director, IT Service Delivery

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div><span style="font-size: 11pt;">Scholar Rock is seeking an experienced and motivated Director of Quality Systems and GxP Compliance. Reporting to the Head of Quality, this position will oversee all aspects of quality systems and regulatory compliance across commercial, clinical, and development activities. The Director will lead the implementation and maintenance of an effective Quality Management System (QMS) to ensure compliance with global regulatory requirements.</span></div>

Senior Director, Global Quality Systems and Compliance

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is seeking an experienced and motivated Senior Director of Global Quality Control. Reporting to the Head of Global Quality, this position is the senior QC leader responsible for establishing and maintaining a phase-appropriate, scalable, and inspection-ready global QC strategy for a fully outsourced development and manufacturing network. This role provides strategic and technical leadership for Quality Control activities executed through external contract laboratories, CMOs, and other testing partners supporting drug substance, drug product, raw materials, in-process, release, and stability programs.</div>

Sr. Director, Global Quality Control

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is seeking an experienced and motivated Senior Director of US Quality Assurance. Reporting to the Head of Global Quality, this position provides strategic and operational leadership for US Quality Assurance with a strong focus on external partner governance, quality risk management, and scalable quality infrastructure to support development through commercialization.</div>

Sr. Director, US Quality Assurance

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>The Director of Demand Planning and S&amp;OP is responsible for the strategic planning, development, and management of the company's processes to ensure accurate planning models for commercial, clinical and early access programs for global markets.&nbsp;The role will have responsibility and accountability for the Sales &amp; Operational Planning process.The position requires strong leadership, problem-solving, and analytical skills to optimize operational efficiency and ensure products are reliably and compliantly supplied across US, EU, Japan and Rest of World. In addition, the candidate will collaborate with and support colleagues in various other supply chain activities at times to ensure continuity of supply to patients.</div><div><br></div><div><br></div><div><b><span style="font-size: 18px;">Position Responsibilities</span></b></div>

Director, Demand Planning and S&OP

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div><span style="font-size: 11pt;">The Medical Director/Senior Director, reporting to the SVP, Clinical Research, will be a member of the late-stage development team, accountable for driving clinical development activities for product candidates from Proof-of-Concept through marketing approval and lifecycle management. The successful candidate will be responsible for providing medical leadership for clinical development activities for apitegromab as well as other product candidates entering late-stage development, in alignment with corporate strategy. This position requires a highly motivated physician scientist with hands-on expertise in advancing late-stage product candidates to deliver life-changing medicines.</span></div>

Medical Director/Sr. Director, Clinical Research

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is seeking a Director of Program Management to serve as the primary operational partner for the Myostatin Core Team. As the organization advances apitegromab through late-stage development and into commercialization, this role ensures the Core Team operates with precision, velocity, and alignment.</div><div><br></div><div>This position is designed for a high-accountability operator who partners seamlessly with the Program Leader. While the Program Leader focuses on executive alignment and organizational strategy ("managing up and out"), the Program Manager focuses on internal team efficacy and execution ("managing in and down"). We require a leader with the professional maturity to navigate the complexities of Lifecycle Management and the humility to personally own the details—from high-level scenario planning to the tactical mechanics of meeting governance and documentation.</div><div><br></div><div><span style="font-size: 18px;"><b>Position Responsibilities: </b></span></div>

Director, Program Management

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is entering a defining chapter as we prepare to launch our first commercial product. We are seeking a Director of Global Facilities who can lead our facilities function with a strategic, enterprise-wide perspective while remaining deeply engaged in day-to-day operations.&nbsp; This is not a purely administrative role. We need a builder — someone who understands what it takes to scale infrastructure in a growing biotech organization and is equally comfortable shaping long-term facility strategy as they are resolving operational issues in real time.</div><div><br></div><div>With facilities across the globe and ready for future expansion, this leader will ensure our environments are safe, compliant, efficient, and built to support both research and commercial readiness.&nbsp; If you are a self-motivated individual who enjoys the challenges and opportunities that come with a growing, transformative organization, this is an excellent opportunity to apply yourself, learn, and make an impact. You thrive in environments where you are involved in both strategic planning (the bigger picture) and execution. As a catalyst for the organization, you value proactive collaboration, communication, and teamwork as essential for success.&nbsp; &nbsp;&nbsp;</div><div><br></div>

Senior Director of Global Facilities

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>The Director or Senior Director, Regulatory Strategy, reporting to the SVP, Global Head of Regulatory Affairs, is responsible for the development and implementation of the Global Strategy for assigned clinical and/or pipeline programs globally depending on the program. As a subject matter expert, this individual will represent regulatory affairs at the appropriate program team, highlighting risks and opportunities to inform program strategy and plan. The successful candidate will lead interactions with the regulatory authorities, directing the preparation and submission of regulatory submissions and correspondence.</div>

Get a job referral to Scholar Rock Holding

Description

Jobs· 10 open

About

Financials

Referrals

Your career is worth investing in.

Get unlimited referrals with Premium.